Schlich Ltd +44(0) 1903 717001 info@schlich.co.uk
Cost Caps at IPEC – Access to Justice for SMEs

Cost Caps at IPEC – Access to Justice for SMEs

The overriding objective of the court system according to the civil procedure rules is that the court is able to deal with cases justly and at proportionate cost. It has long been a concern that justice might be denied to small entities pursuing patent claims because...
A move towards a doctrine of equivalents? – Eli Lilly v Actavis

A move towards a doctrine of equivalents? – Eli Lilly v Actavis

Facts and History On the face of it, the Eli Lilly v Actavis case seems straightforward. Eli Lilly is the proprietor of European patent No. 1313508 which claims:- “Use of pemetrexed disodium in the manufacture of a medicament for use in combination therapy for...
Markush Formulae and SPCs

Markush Formulae and SPCs

Background According to Article 3(a) of the SPC Regulation (European Parliament and Council Regulation 469/2009/EC of 6 May 2009 concerning the supplementary protection certificate for medicinal products) an SPC shall be granted for a medicinal product if the product...
Arrow Declarations – Part III

Arrow Declarations – Part III

Background For more information on Arrow Declarations, please read Part I and Part II of this series of articles. In September 2016, Mr Justice Arnold refused to strike out Fujifilm’s request for an Arrow Declaration, at the request of AbbVie, based on bad faith...